← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 31, 2018Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT07023744CollaboratorPhase 2Oct 1, 2025
- NCT05848713CollaboratorPhase 3Oct 10, 2023
- NCT03567473CollaboratorPhase 3Dec 31, 2018
Details
- Last known activity
- Oct 1, 2025